Heronova Pharmaceuticals

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors	Solid Tumor Malignancies	Recruiting	Phase 1	2026-09-16	NCT07071090
A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, bronchial neoplasm, bronchogenic carcinoma, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Phase 1 / Phase 2	2026-09-16	NCT06873555
A Study of DC6001 Tablet in Healthy Chinese Adult Subjects	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 1	2026-02-18	NCT07417566

Clinical trials